Recurrent Cholangiocarcinoma: Case Report and Literature Review

A B S T R A C T

Conventionally, patients with recurrent cholangiocarcinoma have been treated palliatively, most often with supportive care only. Since intrahepatic cholangiocarcinoma (I-CCA) is an uncommon malignancy, treatment guidelines for I-CCA therapy have a low level of support, and guidelines for the treatment of recurrence are particularly challenging to establish. While a surgical approach is not clearly recommended for recurrent I-CCA in current guidelines, this approach has been reported as reasonable in a particular patient demographic and should be considered [1-3]. Herein we present to you a case of a 56-year-old female patient who presented with local recurrence 1.5 years post resection and was treated surgically.

Keywords

Cholangiocarcinoma, recurrent cholangiocarcinoma, CA 19-9, CEA, papillary intraductal cholangiocarcinoma

Get access to the full version of this article.

Article Info

Article Type

Case Report and Review of the Literature

Publication history

Received: Mon 05, Sep 2022
Accepted: Tue 20, Sep 2022
Published: Sat 24, Sep 2022

Copyright

© 2023 Raja Wakim. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.AJSCR.2022.03.02

Author Info

Adham Alkadri Souad Ghattas Kamal Abi Mousleh Ribal Abi Hadeer Youssef Mahfouz Georges Sakhat Marwan Haddad Raja Wakim

Corresponding Author

Raja Wakim
Head of General Surgery Department, Mount Lebanon Hospital University Medical Center, Lebanon

Figures & Tables

Get access to the full version of this article.

References

1.     Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J et al. (2015) Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol 23: 235-243. [Crossref]

2.     Souche R, Addeo P, Oussoultzoglou E, Herrero A, Rosso E et al. (2016) First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma. Am J Surg 212: 221-229. [Crossref]

3.     Bartsch F, Paschold M, Baumgart J, Hoppe-Lotichius M, Heinrich S et al. (2019) Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma. World J Surg 43: 1105-1116. [Crossref]

4.     Bridgewater J, Galle PR, Khan SA, Llovet JM, Park J-W et al. (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60: 1268-1289. [Crossref]

5.     Saha SK, Zhu AX, Fuchs CS, Brooks GA (2016) Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Oncologist 21: 594-599. [Crossref]

6.     Khan SA, Genus T, Morement H, Murphy A, Rous B et al. (2019) Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol 71: 1261-1262. [Crossref]

7.     Spolverato G, Bagante F, Weiss M, Alexandrescu S, Marques HP et al. (2017) Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer Staging Systems for intrahepatic cholangiocarcinoma. J Surg Oncol 115: 696-703. [Crossref]

8.     Raoof M, Singh G (2019) Rising trends in intrahepatic cholangiocarcinoma incidence and mortality: Getting at the root cause. Hepatobiliary Surg Nutr 8: 301-303. [Crossref]

9.     Hwang S, Lee Y-J, Song G-W, Park K-M, Kim K-H et al. (2015) Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases. J Gastrointest Surg 19: 1291-1304. [Crossref]

10.  Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N et al. (2021) Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 13: 3657. [Crossref]

11.  Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10: 288-291. [Crossref]

12.  Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T et al. (2007) Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: A comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 31: 2016-2022. [Crossref]

13.  Wan X-S (2013) Intraductal papillary neoplasm of the bile duct. World J Gastroenterol 19: 8595-8604. [Crossref]

14.  Tsukahara T, Shimoyama Y, Ebata T, Yokoyama Y, Igami T et al. (2016) Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern. Mod Pathol 29: 293-301. [Crossref]

15.  Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K et al. (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241: 703-712. [Crossref]

16.  Bergquist JR, Ivanics T, Storlie CB, Groeschl RT, Tee MC et al. (2016) Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. J Surg Oncol 114: 475-482. [Crossref]

17.  Zhang S-J, Hu P, Wang N, Shen Q, Sun A-X et al. (2013) Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol 20: 3596-3602. [Crossref]

18. Ma KW, Cheung TT, Leung B, She BWH, Chok KSH et al. (2019) Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis. Medicine (Baltimore) 98: e14013. [Crossref]